Prospects for ancillary treatment of sinusitis in the 1990s

The Journal of Allergy and Clinical Immunology

Volumn 90, Issue 3 PART 2, 1992, Pages 478-495

  Zeiger, Robert S ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

adenosine triphosphate; hyperthermia; iodinated glycerol; mediator antagonists; mucociliary clearance; mucoregulators; N acetylcysteine; Sinusitis; topical corticosteroids; agonists

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHISTAMINIC AGENT; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CROMOGLYCATE DISODIUM; CYSTEINE DERIVATIVE; EXPECTORANT AGENT; IODINATED GLYCEROL; MUCOLYTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NOSE SPRAY; VIRUS VACCINE;

BODY POSTURE; CHRONIC SINUSITIS; CONFERENCE PAPER; CORTICOSTEROID THERAPY; EXERCISE; HAND WASHING; HUMAN; HYPERTHERMIC THERAPY; IMMUNIZATION; MUCOCILIARY CLEARANCE; MUCUS; NOSE BREATHING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHINOVIRUS; TOPICAL DRUG ADMINISTRATION; UPPER RESPIRATORY TRACT INFECTION; VISCOELASTICITY;

ADRENERGIC ALPHA-AGONISTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GLUCOCORTICOIDS; HUMAN; HYPERTHERMIA, INDUCED; MUCOCILIARY CLEARANCE; MUCOUS MEMBRANE; NASAL DECONGESTANTS; RESPIRATORY TRACT INFECTIONS; RHINOVIRUS; SINUSITIS; VIRUS REPLICATION;

EID: 0026713349     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-6749(92)90173-Y     Document Type: Article

References (120)

1. Allergic and nonallergic rhinitis classification and pathogenesis Part II Nonallergic rhinitis
2. Mucus production in chronic maxillary sinusitis: a quantitative histopathological study
3. Effects of phenylpropanolamine on ostial and nasal airway resistance in healthy individuals
4. Posture and nasal patency
5. Effects of exercise on nasal resistance and nasal blood flow
6. Nasal mucosal reactions, catecholamines and lactate during physical exercise
7. Exercise-induced nasal obstruction in patients with allergic rhinitis
8. Hot news on the common cold
9. Death and transfiguration of a problem
10. Traiteniente du coryza infectieux et des rhinities persistantes allergiques par la thermotherapie
11. Effects of steam inhalation on nasal patency and nasal symptoms in patients with the common cold
12. Effect on inhaling heated vapor on symptoms of the common cold
13. Local hyperthermia benefits natural and experimental colds
14. Effects of elevated intranasal temperature on subjective and objective findings in perennial rhinitis
15. The effect of warm inhalation therapy on the ciliated nasal epithelium
16. Modification of inspired air
17. Human nasal mucous flow rates
18. Factors influencing ciliary beat measurements
19. Effects of drinking hot water, cold water, and chicken soup on nasal mucus velocity and nasal airflow resistance
20. Studies on the maxillary ostial function in cases with maxillary pain, intrasinusal cysts and chronic sinusitis
21. Oxygen tension in the human maxillary sinus under normal and pathological conditions
22. Controlled comparison of a new antihistamine-decongestant combination to its individual components
23. Studies of the effect of peroral fenylpropanolamin on the functional size of the human maxillary ostium
24. Effects of phenylpropanolamine on ostial and nasal patency in patients treated for chronic maxillary sinusitis
25. Decongestion of nasal mucous membranes by oral medication in acute rhinitis
26. Follow-up study of pseudoephedrine users
27. Comparison of nasal airway patency changes after treatment with oxymetazoline and pseudoephedrine
28. A double dose of phenylpropanolamine causes transient hypertension
29. The effect of topical decongestants on blood flow in normal and infected nasal mucosa
30. Function and structure of the nasal mucosa after 6 weeks use of nose-drops
31. Sustained use of xylometazoline nose drops aggravates vasomotor rhinitis
32. The effect of nasal decongestants on nasal mucus velocity
33. Allergic and nonallergic rhinitis in Allergy
34. Treatment of acute maxillary sinusitis. V. Amoxicillin, azidocillin, phenylpropanolamine, and pivampicillin
35. Nasal ciliary ultrastructure and function in patients with primary ciliary dyskinesia compared with that in normal subjects and in subjects with various respiratory diseases
36. Autoregulation of beat frequency in respiratory ciliated cells. Demonstration by viscous loading
37. Immotile cilia syndrome in children
38. Dynamic viscoelasticity of nasal mucus from children with chronic sinusitis
39. Human nasal mucous flow rates
40. Mucociliary clearance in chronic sinusitis: related human nasal clearance and in vitro bullfrog palate clearance
41. Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol
42. A device for nasal irrigation
43. Physical properties of sputum IV Effects of 100 percent humidity and water mist
44. Beneficial effects of propylene glycol and polyethylene glycol and saline in the treatment of perennial rhinitis
45. Primary ciliary dyskinesia: evaluation and management
46. Activation of nasal cilia in immotile cilia syndrome
47. Chronic maxillary sinusitis: energy metabolism in sinus mucosa and secretion
48. The effect of ATP on the ciliary activity of normal and pathological human respiratory mucosa in vitro
49. Activation of the nasal cilia: preliminary study on healthy subjects
50. Activation of the impaired nasal mucociliary function: a preliminary clinical study
51. Activation of the impaired nasal mucociliary transport in children: preliminary report
52. Activation of mucociliary function in chronic rhinitis: A placebo-controlled study
53. Mucociliary function in the respiratory tract as influenced by drugs
54. Tracheal mucous velocity in normal man and patients with obstructive lung disease; effects of terbutaline
55. Impaired tracheal mucus transport in allergic bronchoconstriction: effect of terbutaline pretreatment
56. Mucociliary function in the respiratory tract as influenced by physiochemical factors
57. Inhibition of the immediate allergic reaction in the nose by the beta-2 adrenostimulant fenoterol
58. Intranasal ipratropium: a new treatment for perennial rhinitis
59. Anticholinergic drugs for rhinitis
60. Influence of inhaled atropine on lung mucociliary function in humans
61. Ipratropium bromide: mucociliary clearance rates and airway resistance in normal subjects
62. Quantitative and selective bronchial clearance studies using technetium-sulfate particles
63. Influence of 0.2 mg ipratropium bromide on mucociliary clearance in patients with chronic bronchitis
64. Acute effect of ipratropium bromide at therapeutic dose on mucus transport of adult asthmatics
65. Ordinary and high dose ipratropium bromide
66. Is histamine responsible for the symptoms of rhinovirus colds? A look at the inflammatory mediators following infection
67. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat
68. Ineffectiveness of oral terfenadine in natural colds: evidence against histamine as a mediator of common cold symptoms
69. Inorganic and organic iodides
70. Effects of iodopropylidene glycerol on tracheobronchial clearance in stable, chronic bronchitic patients
71. The National Mucolytic Study: results of a randomized, double-blind, placebo-controlled study of iodinated glyercol in chronic obstructive bronchitis
72. Acetylcysteine: a drug that is much more than a mucokinetic
73. Acetylcysteine: a drug with an interesting past and a fascinating future
74. An evaluation of the effect of nebulized N-acetylcysteine on sputum consistency
75. Clinical evaluation of acetylcysteine in the treatment of patients with chronic obstructive bronchitis: a balanced double-blind trial with placebo control
76. Long-term oral acetylcysteine in chronic bronchitis: a double-blind controlled study
77. Oral acetylcysteine reduces exacerbation rate in chronic bronchitis: report of a trial organized by the Swedish Society for Pulmonary Diseases
78. Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction
79. Agents that affect respiratory mucus
80. S-carboxymethylcysteine in the fluidation of sputum and treatment of chronic airway obstruction
81. The expectorant effect of glycerol guaiacolate in patients with chronic bronchitis (a controlled in vitro and in vivo study)
82. Antitussive effect of guaifenesin in young adults with natural colds (objective and subjective assessment)
83. Ambroxol therapy in simple chronic bronchitis: effects on subjective symptoms and ventilatory function
84. Evaluation of a new mucolytic drug
85. Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus
86. Modification of the rheological properties of mucus by drugs
87. Clinical trial with oral acetylcysteine in chronic sinusitis [Abstract]
88. Reversibility of reduced mucociliary clearance in chronic sinusitis
89. The treatment of chronic maxillary sinusitis by inhalation therapy with bisolvon
90. Is there such an entity as allergic sinusitis [Abstract]?
91. Cytotoxicity of human eosinophil granule major basic protein to human nasal sinus mucosa in vitro
92. Eosinophil cationic protein stimulates and major basic protein inhibits air-way mucus secretion
93. Response of the nonallergic rhinitis with eosinophilia (NARES) syndrome to 4% cromolyn sodium nasal solution
94. Intranasal sodium cromoglycate in post-catarrhal hyperreactive rhinosinusitis: a double-blind placebo controlled trial
95. Topical corticosteroids in the management of rhinitis
96. The in vitro and in vivo effect of a new nonhalogenated corticosteroidbudesonide-aerosol on human ciliary epithelial function
97. Influence of topical beclomethasone dipropionate suspension on human nasal mucociliary activity
98. Efficacy of endonasal neomycin-tixocortol pivalate irrigation in the treatment of chronic allergic and bacterial sinusitis
99. Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis: a controlled study
100. Assessment of flunisolide nasal spray vs. placebo as an adjunct to antibiotic treatment of sinusitis [Abstract]
101. Depomethylprednisolone in the treatment of ragweed hay fever
102. Surgical versus medical treatment of nasal polyps
103. Reply to correspondence
104. Resolution of otitis media with effusion with the use of a stepped treatment regimen of trimethoprim-sulfamethoxazole and prednisone
105. Proposed mechanisms of aspirin sensitivity reactions [Editorial]
106. Effect of aspirin on nasal resistance to airflow
107. Effects of aspirin on nasal responses in atopic subjects
108. Treatment of ragweed hayfever with flurbiprofen, a cyclooxygenase-inhibiting drug
109. Apsirinsensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin
110. Aspirin-sensitive rhinosinusitis the clinical syndrome and effects of aspirin administration
111. Long-term effects of aspirin desensitization: treatment for aspirinsensitive rhinosinusitis-asthma
112. Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin
113. The effect of aspirin on lung mucociliary clearance
114. Nasal provocation test with lysine acetylsalicylate in aspirin-sensitive patients
115. Aspirinsensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin
116. 4, and 15-lipoxygenase products
117. Increased biosynthesis of platelet-activating factor in activated human eosinophils
118. How and why the nose runs